Log In
Print
BCIQ
Print
Print this Print this
 

IT-235 (formerly NKP-2235)

  Manage Alerts
Collapse Summary General Information
Company Intezyne Technologies Inc.
DescriptionOral gallium-based small molecule targeting the endoplasmic reticulum
Molecular Target Endoplasmic reticulum aminopeptidase 1 (ERAP1) (ARTS1) (ERAAP)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today